Introduction
Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquiliser but was never marketed.
It acts as a selective 5-HT1A receptor partial agonist.
Similarly to other azapirones such as buspirone, revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite.
As a result, it also acts as an α2-adrenergic receptor antagonist to an extent.
This page is based on the copyrighted Wikipedia article < https://en.wikipedia.org/wiki/Revospirone >; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA.
Mental Health Matters 